PMID- 34332429 OWN - NLM STAT- MEDLINE DCOM- 20211019 LR - 20211019 IS - 1573-2509 (Electronic) IS - 0920-9964 (Linking) VI - 235 DP - 2021 Sep TI - Enhancing stress reactivity and wellbeing in early schizophrenia: A randomized controlled trial of Integrated Coping Awareness Therapy (I-CAT). PG - 91-101 LID - S0920-9964(21)00275-9 [pii] LID - 10.1016/j.schres.2021.07.022 [doi] AB - Individuals with schizophrenia spectrum disorders (SSD) are at heightened risk for exposure to stressful life events which can lead to increased sensitivity to stress and a dysregulated stress response, which are in turn associated with poor long-term functioning. Stress reactivity is thus a promising treatment target in the early stages of SSD. Integrated-Coping Awareness Therapy (I-CAT) is a manualized intervention integrating mindfulness and positive psychology to target a dysregulated stress response in SSD. The current study is a preliminary randomized-controlled trial (RCT) comparing I-CAT (n = 18) with treatment as usual (TAU; n = 18) in individuals in the early stages of SSD. I-CAT was hypothesized to be more effective than TAU on primary outcomes: increasing positive emotions, decreasing negative emotions, reducing stress, and improving functioning and quality of life; and secondary outcomes: reducing symptoms, increasing mindfulness, and improving overall well-being. Excellent therapy attendance rates, low study attrition, and positive participant feedback demonstrated that I-CAT was a feasible and well-tolerated psychosocial intervention. Results suggest I-CAT led to greater reduction in symptoms (i.e., overall, negative, and disorganized symptoms), increased observational mindfulness, increased endorsement of a sense of purpose in life, and preservation of work abilities and school social functioning compared with TAU. Future work should replicate and extend these findings in a larger-scale RCT. CI - Copyright (c) 2021 Elsevier B.V. All rights reserved. FAU - Halverson, Tate F AU - Halverson TF AD - Department of Psychology and Neuroscience, The University of North Carolina at Chapel Hill, United States of America. Electronic address: tate.halverson@unc.edu. FAU - Meyer-Kalos, Piper S AU - Meyer-Kalos PS AD - Department of Psychiatry and Behavioral Sciences, University of Minnesota Medical School, United States of America. FAU - Perkins, Diana O AU - Perkins DO AD - Department of Psychiatry, The University of North Carolina at Chapel Hill, United States of America. FAU - Gaylord, Susan A AU - Gaylord SA AD - Department of Physical Medicine and Rehabilitation, The University of North Carolina at Chapel Hill, United States of America. FAU - Palsson, Olafur S AU - Palsson OS AD - Department of Medicine, The University of North Carolina at Chapel Hill, United States of America. FAU - Nye, Lana AU - Nye L AD - College of Social Work, The University of Utah, United States of America. FAU - Algoe, Sara B AU - Algoe SB AD - Department of Psychology and Neuroscience, The University of North Carolina at Chapel Hill, United States of America. FAU - Grewen, Karen AU - Grewen K AD - Department of Psychiatry, The University of North Carolina at Chapel Hill, United States of America. FAU - Penn, David L AU - Penn DL AD - Department of Psychology and Neuroscience, The University of North Carolina at Chapel Hill, United States of America; School of Behavioural and Health Sciences, Australian Catholic University, Australia. LA - eng GR - R33 MH100250/MH/NIMH NIH HHS/United States GR - R21 MH100250/MH/NIMH NIH HHS/United States PT - Journal Article PT - Randomized Controlled Trial PT - Research Support, N.I.H., Extramural DEP - 20210728 PL - Netherlands TA - Schizophr Res JT - Schizophrenia research JID - 8804207 SB - IM MH - Adaptation, Psychological MH - Humans MH - *Mindfulness MH - Quality of Life MH - *Schizophrenia/therapy OTO - NOTNLM OT - Early intervention OT - First episode psychosis OT - Mindfulness OT - Positive psychology OT - Stress reactivity EDAT- 2021/08/01 06:00 MHDA- 2021/10/21 06:00 CRDT- 2021/07/31 20:28 PHST- 2020/10/20 00:00 [received] PHST- 2021/03/14 00:00 [revised] PHST- 2021/07/19 00:00 [accepted] PHST- 2021/08/01 06:00 [pubmed] PHST- 2021/10/21 06:00 [medline] PHST- 2021/07/31 20:28 [entrez] AID - S0920-9964(21)00275-9 [pii] AID - 10.1016/j.schres.2021.07.022 [doi] PST - ppublish SO - Schizophr Res. 2021 Sep;235:91-101. doi: 10.1016/j.schres.2021.07.022. Epub 2021 Jul 28.